Nihil Abraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nihil Abraham has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Ashutosh Kumar
Washington University
2 shared publications - John D. Tranter
Department of Internal Medicine, Cardiovascular Division (Q.Y., Y.Z., J.M., P.A., N.J., J.D.T., T.M.A.E.-A., M.R., R.S.), Washington University School of Medicine, Saint Louis, MO
2 shared publications - Litao Xie
Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications - Rajan Sah
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications Ryan T. Mikami
Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications- Yonghui Zhao
Department of Internal Medicine, Cardiovascular Division (Q.Y., Y.Z., J.M., P.A., N.J., J.D.T., T.M.A.E.-A., M.R., R.S.), Washington University School of Medicine, Saint Louis, MO
2 shared publications
Latest Publications
- Open Access
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadt6366
Lysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism
The lysosome integrates anabolic signaling and nutrient sensing to regulate intracellular growth pathways. The leucine-rich repeat–containing 8 (LRRC8) channel complex forms a lysosomal anion channel and regulates PI3K-AKT-mTOR signaling, skeletal muscle differentiation, growth, and systemic glucose metabolism. Here, we define the endogenous LRRC8 subunits localized to a subset of lysosomes in differentiated myotubes. We show that LRRC8A affects leucine-stimulated mTOR; lysosome size; number; pH; expression of lysosomal proteins LAMP2, P62, and LC3B; and lysosomal function. Mutating an LRRC8A lysosomal targeting dileucine motif sequence (LRRC8A-L706A;L707A) in myotubes recapitulates the abnormal AKT signaling and altered lysosomal morphology and pH observed in LRRC8A knockout cells. In vivo, LRRC8A-L706A;L707A knock-in mice exhibit increased adiposity, impaired glucose tolerance and insulin resistance associated with reduced skeletal muscle PI3K-AKT-mTOR signaling, glucose uptake, and impaired incorporation of glucose into glycogen. These data reveal a lysosomal LRRC8-mediated metabolic signaling function regulating lysosomal function, systemic glucose homeostasis, and insulin sensitivity.
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadt6366
Open AccessLysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism
The lysosome integrates anabolic signaling and nutrient sensing to regulate intracellular growth pathways. The leucine-rich repeat–containing 8 (LRRC8) channel complex forms a lysosomal anion channel and regulates PI3K-AKT-mTOR signaling, skeletal muscle differentiation, growth, and systemic glucose metabolism. Here, we define the endogenous LRRC8 subunits localized to a subset of lysosomes in differentiated myotubes. We show that LRRC8A affects leucine-stimulated mTOR; lysosome size; number; pH; expression of lysosomal proteins LAMP2, P62, and LC3B; and lysosomal function. Mutating an LRRC8A lysosomal targeting dileucine motif sequence (LRRC8A-L706A;L707A) in myotubes recapitulates the abnormal AKT signaling and altered lysosomal morphology and pH observed in LRRC8A knockout cells. In vivo, LRRC8A-L706A;L707A knock-in mice exhibit increased adiposity, impaired glucose tolerance and insulin resistance associated with reduced skeletal muscle PI3K-AKT-mTOR signaling, glucose uptake, and impaired incorporation of glucose into glycogen. These data reveal a lysosomal LRRC8-mediated metabolic signaling function regulating lysosomal function, systemic glucose homeostasis, and insulin sensitivity.
- Open Access
- 28 August 2025
- Published by American Society of Hematology in Blood
- Vol. 146 (9) , 1110-1126
LRRC8 complexes are ATP release channels that regulate platelet activation and arterial thrombosis
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in leucine-rich repeat–containing 8 (LRRC8) protein subunits that form the volume-regulated anion channel (VRAC), which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume; adhesion; and agonist-stimulated activation, aggregation, adenosine triphosphate (ATP) secretion, and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser injury–induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without prolonged bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium–phosphoinositide 3-kinase–protein kinase B signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets, which positively regulates platelet function and thrombosis, providing a proof of concept for a novel antithrombotic drug target.
- 28 August 2025
- Published by American Society of Hematology in Blood
- Vol. 146 (9) , 1110-1126
Open AccessLRRC8 complexes are ATP release channels that regulate platelet activation and arterial thrombosis
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in leucine-rich repeat–containing 8 (LRRC8) protein subunits that form the volume-regulated anion channel (VRAC), which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume; adhesion; and agonist-stimulated activation, aggregation, adenosine triphosphate (ATP) secretion, and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser injury–induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without prolonged bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium–phosphoinositide 3-kinase–protein kinase B signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets, which positively regulates platelet function and thrombosis, providing a proof of concept for a novel antithrombotic drug target.